益气固表丸联合平喘敷贴膏 治疗慢性阻塞性肺疾病稳定期临床研究

2017-06-10 03:48:28李风森徐丹高振李争荆晶张艳丽王晶
中国中医药信息杂志 2017年6期
关键词:慢性阻塞性肺疾病稳定期

李风森+徐丹+高振+李争+荆晶+张艳丽+王晶

摘要:目的 觀察益气固表丸联合平喘敷贴膏治疗慢性阻塞性肺疾病(COPD)稳定期肺脾气虚证临床疗效及安全性。方法 采用随机、双盲、安慰剂平行对照法,将266例COPD患者随机分为4组。试验Ⅰ组(72例)予益气固表丸,每次10丸,每日3次,口服;同时予模拟平喘敷贴膏(空白药袋),置于肺俞、膻中、脾俞、风门、定喘,每日上午11时外敷并外置发热贴,每次4~6 h,每周2次。试验Ⅱ组(64例)予模拟益气固表丸合平喘敷贴膏,试验Ⅲ组(64例)予益气固表丸合平喘敷贴膏,对照组(66例)予模拟益气固表丸合模拟平喘敷贴膏,方法同上。连续治疗3个月,随访3个月。观察患者中医症状评分、第1秒用力呼气容积占预计值的百分比(FEV1%)、用力肺活量占预计值的百分比(FVC%)、COPD评估测试量表(CAT)评分、BODE指数、呼吸困难指数(mMRC)评分、6 min步行试验(6MWT)等。结果 治疗后及治疗后3个月,3个试验组中医症状评分改善程度优于对照组(P<0.05),CAT评分、mMRC评分、BODE指数改善程度及6MWT增加距离优于对照组(P<0.05),mMRC评分、BODE指数改善程度试验Ⅰ、Ⅱ组优于试验Ⅲ组(P<0.05);治疗后3个月,3个试验组FVC%改善程度优于对照组(P<0.05),试验Ⅱ、Ⅲ组FEV1%改善程度优于对照组(P<0.05)。结论 益气固表丸合平喘敷贴膏治疗COPD稳定期肺脾气虚证疗效显著。

关键词:益气固表丸;平喘敷贴膏;慢性阻塞性肺疾病;稳定期

DOI:10.3969/j.issn.1005-5304.2017.06.006

中图分类号:R259.63 文献标识码:A 文章编号:1005-5304(2017)06-0022-05

Abstract: Objective To observe efficacy and safety of Yiqi Gubiao Pill combined with Pingchuan External Application Ointment for the treatment of COPD (lung-spleen qi deficiency type) at a stable stage. Methods A randomized, double-blind, and placebo-controlled method was used. Totally 266 cases of patients diagnosed with COPD lung-spleen qi deficiency syndrome were randomly divided into four groups. Experimental Ⅰ group (72 cases) was given Yiqi Gubiao Pill, 10 pills each time, three times a day, orally; at the same time, experimental Ⅰ group was given simulated Pingchuan External Application Ointment (blank medical bag), for Feishu (BL13), danzhong (RN17), Pishu (BL20), Fengmen (BL12), and Dingchuan, external application at 11am each day, external heating stickers, 4-6 h each time, twice a week. Experimental Ⅱ group (64 cases) was given simulated Yiqi Gubiao Pill combined with Pingchuan External Application Ointment. Experimental Ⅲ (64 cases) was given Yiqi Gubiao Pill combined with

Pingchuan External Application Ointment. Control group (66 cases) was given simulated Yiqi Gubiao Pill combined with simulated Pingchuan External Application Ointment. The treatment lasted for three months, and the follow-up was three months. TCM symptom scores, FEV1%, FVC%, CAT, BODE index, mMRC, and 6MWT were observed. Results After three-month treatment and three-month follow-up, the improvement of TCM symptom scores of the 3 experimental groups was better than the control group (P<0.05). The improvement of CAT, mMRC, BODE index, 6MWT, mMRC in the three treatment groups were better than the control group (P<0.05). The improvement of mMRC and BODE in experimental Ⅰ and Ⅱ groups were better than those of experimental Ⅲ group (P<0.05). After three-month treatment, the improvement of FVC% in the three experimental groups was better than the control group (P<0.05). The improvement of FEV1% in the experimental Ⅱ and Ⅲ groups was better than the control group (P<0.05). Conclusion Yiqi Gubiao Pill combined with Pingchuan External Application Ointment has obvious efficacy for the treatment of COPD with lung-spleen qi deficiency type.endprint

Key words: Yiqi Gubiao Pill; Pingchuan External Application Ointment; chronic obstructive pulmonary disease; stable stage

慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是一种具有气流受限特征的疾病,气流受限不完全可逆、呈进行性发展,属中医学“咳嗽”“痰饮”“肺胀”等范畴。中国40岁以上人群COPD患病率为9.9%,男性高于女性,患病率随年龄增长而上升[1]。新疆农村常住人口调查显示,新疆农村地区COPD总患病率为7.5%[2],新疆维吾尔族15岁上农村居民COPD患病率约为4.0%[3]。目前西医治疗COPD急性期有較大优势,但对稳定期缺乏良策,通过治疗稳定期而改善COPD患者状况预防急性发作成为医学界面临的问题。……

登录APP查看全文

猜你喜欢
慢性阻塞性肺疾病稳定期
自拟补肺饮治疗慢性阻塞性肺疾病稳定期(肺肾气虚证)的临床研究
基层中医药(2022年5期)2022-10-24 01:27:22
布地奈德福莫特罗治疗慢阻肺稳定期,慢阻肺合并肺癌稳定期患者的临床疗效
无创正压通气联合参麦注射液治疗COPD并呼吸衰竭的临床效果
多元性护理干预对慢性阻塞性肺疾病长期家庭氧疗依从性的应用价值
今日健康(2016年12期)2016-11-17 14:01:24
无创机械通气联合盐酸氨溴索雾化治疗慢性阻塞性肺疾病伴Ⅱ型呼吸衰竭的效果分析
授权理论在使用无创呼吸机COPD患者健康教育中的应用
蛤蚧六参汤对稳定期慢性阻塞性肺疾病的影响
中成药(2014年9期)2014-02-28 22:28:47
舒利迭联合喘可治注射液治疗COPD稳定期的临床疗效观察
中医特色疗法对COPD稳定期的治疗进展
中医研究(2013年9期)2013-03-11 20:27:43
中西医联合治疗稳定期慢性阻塞性肺疾病的临床疗效观察